---
title: 'Director, Clinical Science at Lyell Immunopharma'
canonical: 'https://feeny.ai/job/director-clinical-science-lyell-immunopharma-united-states-8qzzt8p94g0x'
type: 'job'
last_seen: '2026-09-13'
---

# Director, Clinical Science at Lyell Immunopharma

- **Company:** Lyell Immunopharma
- **Location:** United States
- **Posted:** 2026-08-14
- **Last confirmed live:** 2026-09-13
- **Apply:** https://job-boards.greenhouse.io/lyellimmunopharma/jobs/7871580003

## Job description

Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. And for patients with hematologic malignancies, there is a need for next-generation cell therapies that can deliver increased response rates and longer duration of response.  We are a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell’s product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.

This role can be based out of either our Seattle, WA or South San Francisco, CA offices.

The Director, Clinical Science is a critical scientific partner in the clinical development of Lyell’s potential cell therapies. Working in close partnership with medical monitors and cross-functional study teams, this role supports the design, execution, and oversight of clinical trials — ensuring adherence to regulatory standards, Good Clinical Practice (GCP), and scientific rigor. The role will focus initially on supporting study medical monitoring for the pivotal PiNACLE and PiNACLE-H2H studies, with the agility to support additional programs as the organization’s needs evolve.

Reporting to the Vice President, Clinical Development, this is a hands-on, collaborative role centered on partnering, support, and cross-functional execution.

## KEY ROLE AND RESPONSIBILITIES

Study Medical Monitoring

- Partner with medical monitor(s) in study oversight, data review, and interpretation across assigned programs — initially the pivotal PiNACLE and PiNACLE-H2H studies, with agility to pivot and support other programs as organizational needs evolve.
- Support the medical monitor in execution of clinical trials, ensuring adherence to the protocol, regulatory requirements, and Good Clinical Practice (GCP) guidelines.
- Contribute to patient safety monitoring by partnering with the medical monitor to identify and support site management of adverse events per protocol requirements, including required timely reporting to regulatory bodies.

Protocol Design & Clinical Trial Planning

- Collaborate in the design and development of clinical trial protocols, ensuring they meet scientific, medical, and regulatory requirements, including selection of endpoints and patient populations.
- Assist in the planning and design of clinical trials, including the selection of endpoints and patient populations.

Data Review, Interpretation & Publications

- Coordinate cross-functionally with the study team to ensure accurate and timely data collection, analysis, and reporting; assist with review and interpretation of clinical and translational data to make informed decisions about study execution.
- Plan and coordinate data cleaning activities to support the data analyses needed for planned publications (abstracts, presentations, and manuscripts).

Regulatory Submissions & Documentation

- Support and contribute to the preparation and review of documents for regulatory submissions (IND, BLA, etc.), including clinical study reports, Investigator’s Brochures, and responses to regulatory agency inquiries.

Cross-Functional & External Collaboration

- Collaborate cross-functionally with key Lyell study and program teams — including (but not limited to) Clinical Operations, Translational Sciences, Biostatistics, Data Management, Pharmacovigilance, Regulatory Affairs, and Medical Affairs — to ensure seamless trial execution.
- Contribute to regularly planned and ad hoc interactions with external stakeholders and vendors, including study site investigators and staff, steering committees, Safety/Data Monitoring Committees, key opinion leaders (KOLs), and Contract Research Organizations (CROs), to collaboratively identify issues and solutions, facilitate trial operations and patient enrollment, and maintain high standards of scientific integrity.
- Participate in and support pan-study external meetings (e.g., regularly planned site study staff meetings and PI/Sub-I meetings), as well as site visits and meetings with PIs/Sub-Is/staff.
- Support preparations for, and participate as requested in, medical-scientific meetings/congresses, study steering committee meetings, and SMC/DMC preparations and meetings.

Innovation & Risk Management

- Identify opportunities for innovation and improvement in clinical trial methodologies and therapeutic approaches, including use of Artificial Intelligence methods.
- Consistently monitor for risks and recommend actions to address issues in a timely manner.

## PREFERRED EDUCATION

- PhD, PharmD, PA-C, ARNP, MS, or BSRN in a related field.
- Scientific or clinical education in a relevant field (e.g., immunology, oncology, molecular biology, or health care delivery).

## PREFERRED EXPERIENCE

- 10+ years related experience delivering results in a clinical, research or pharmaceutical organization
- A minimum of 4 years’ experience in clinical development, with 7+ years related experience, ideally in oncology, with a focus on cell therapy, T-cell engager, or immuno-oncology.
- Demonstrated experience supporting the design, execution, and oversight of clinical trials.

KNOWLEDGE, SKILLS, AND ABILITIES

- Proficiency in clinical trial design, regulatory submissions, and data interpretation; familiarity with GCP and regulatory guidelines.
- Strong analytical, organizational, and communication skills; ability to work effectively in a collaborative, fast-paced environment.
- Ability to manage multiple priorities in a fast-paced, dynamic environment.

The salary range for this position is $220,000 to $260,000, annually, with the opportunity to earn an annual bonus. The salary range is an estimate, and the actual salary may vary based on Lyell’s compensation practices and an applicant’s qualifications and experience. Employees are also eligible to participate in Lyell’s Equity Incentive Plan.

At Lyell, we believe that highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse and inclusive culture for all employees. Lyell is proud to be an equal opportunity employer and does not discriminate on the basis of race, color, citizenship status, national origin, ancestry, sex, sexual orientation, age, religion, creed, physical or mental disability, medical condition, marital status, veteran status or any other characteristics protected under applicable federal, state and local laws.

## About Lyell Immunopharma

## Company Overview
- **One-liner**: Lyell Immunopharma is a clinical-stage biotechnology company advancing next-generation CAR T-cell therapies designed to deliver durable remissions for patients with cancer.
- **Entity Type**: Public (ticker not explicitly confirmed in provided sources; investor relations page indicates public reporting)  
- **Headquarters**: South San Francisco, California, United States  
- **Founded**: Not publicly available from provided sources  
- **Founders**: Rick Klausner, M.D. (Founder & Chairman), Crystal Mackall, M.D. (Founder), Stan Riddell, M.D. (Founder)  

## Core Business
- **Primary industry**: Biotechnology – Cell Therapy / Oncology  
- **Target customers**: B2B (healthcare providers, clinical trial sites, and patients seeking one-time cell therapies)  
- **Mission / purpose**: “To fully realize the curative potential of cell therapy for patients with cancer” – advancing next-generation CAR T cells that provide potent, long-lasting responses in both hematologic malignancies and solid tumors.  

## Products & Services
- **Ronde-Cel (LYL797)**: A next-generation CAR T-cell product candidate targeting ROR1 in solid tumors; currently presenting clinical and translational data at conferences like ASH 2025.  
- **Other pipeline candidates**: Multiple undisclosed product candidates for hematologic malignancies and solid tumors, designed with novel CAR constructs, T-cell exhaustion‑resistance technologies, and proprietary manufacturing protocols.  

## Market Standing
- **Valuation / Market Cap**: Not publicly available from provided sources  
- **Key Metric**: Clinical-stage; no approved product yet. Most recent disclosed financing is a $50 million tranche of equity private placement (closed April 2026).  
- **Notable Investors / Partners**: Not explicitly listed in provided data; investors likely include those from private placements and institutional holders (details not available).  
- **Growth Signals**:  
  - Clinical progress with Ronde-Cel in solid tumors  
  - State-of-the-art manufacturing facility in Bothell, WA, approved for clinical and commercial production  
  - Active pipeline across hematologic and solid tumor indications  
  - Establishment of three West Coast hubs (South San Francisco HQ, Seattle, Bothell)  

## Competitive Advantages
- **Proprietary T-cell biology**: Pioneering approaches to prevent T-cell exhaustion, enabling longer‑lived and more potent cancer killing.  
- **End‑to‑end control**: Own and operate a dedicated manufacturing facility, ensuring supply chain control and product quality.  
- **Founding by cell‑therapy pioneers**: Founders (Klausner, Mackall, Riddell) are leaders in the field, providing deep scientific expertise.  

## Strategic Focus
- **Pipeline advancement**: Progress next‑generation CAR T candidates through clinical trials, aiming to improve outcomes over first‑generation CAR T therapies.  
- **Solid tumor expansion**: Aggressively develop therapies for solid tumors where current cell therapies have limited efficacy.  
- **Manufacturing scale‑up**: Leverage internal manufacturing to accelerate development and eventual commercialization.  

## Why Work Here
- **Culture**: Described as “grounded in science, infused with courage, and powered by respect and collaboration.” Employees report feeling welcomed and able to contribute, with diverse perspectives valued.  
- **Work model**: Hybrid – in‑office collaboration days and weekly lunches; offices in South San Francisco, Seattle (South Lake Union), and Bothell.  
- **Benefits**:  
  - Comprehensive medical, dental, vision (up to 100% premium for employees, 85% for dependents)  
  - Employee Stock Purchase Plan (ESPP) with 15% discount  
  - 401(k) matching  
  - FSA/HSA options  
  - Company‑sponsored life insurance, short‑ and long‑term disability  
  - Paid vacation and sick time  
  - Commuter benefit  
  - Wellness program (mental health, physical fitness, financial wellness)  

## Sources
1. [Lyell.com – Company Overview](https://www.lyell.com/)  
2. [Lyell.com – Careers](https://www.lyell.com/careers/)  
3. [Lyell.com – Job Openings](https://www.lyell.com/careers/job-openings/)  
4. [Lyell.com – Investor Relations](https://ir.lyell.com/investor-relations)  
5. [Lyell.com – Leadership](https://www.lyell.com/about/leadership/)

## Other roles at Lyell Immunopharma

- [Director, Medical Writing](https://feeny.ai/job/director-medical-writing-lyell-immunopharma-united-states-vhfy2mbbyfy2) — United States
- [Associate Director, FP&A](https://feeny.ai/job/associate-director-fp-a-lyell-immunopharma-south-san-francisco-california-xv34y6x78vjv) — South San Francisco California, United States
- [Associate Director, Clinical Development Program Management](https://feeny.ai/job/associate-director-clinical-development-program-management-lyell-immunopharma-p0yy7kq7ngdh) — South San Francisco California, United States
- [Senior Manager, Clinical Site Budgets and Outsourcing -  contract position](https://feeny.ai/job/senior-manager-clinical-site-budgets-and-outsourcing-contract-position-lyell-se4hdrf04a9b) — United States
- [Director or Senior Director, Investor Relations and Corporate Communications](https://feeny.ai/job/director-or-senior-director-investor-relations-and-corporate-communications-e9h5mes0s5ce) — United States
- [Director, Regulatory Affairs](https://feeny.ai/job/director-regulatory-affairs-lyell-immunopharma-seattle-washington-79r3gcjrr7eh) — Seattle Washington, United States / South San Francisco California, United States
- [Associate Director, CMC Regulatory](https://feeny.ai/job/associate-director-cmc-regulatory-lyell-immunopharma-seattle-washington-ase0cen8tsjf) — Seattle Washington, United States
- [Director, Medical Affairs Operations](https://feeny.ai/job/director-medical-affairs-operations-lyell-immunopharma-united-states-2yw8q0bfn11t) — United States
- [Principal, Quality Assurance](https://feeny.ai/job/principal-quality-assurance-lyell-immunopharma-bothell-washington-2n68z54b0gcx) — Bothell Washington, United States
- [Vice President, Commercial Strategy](https://feeny.ai/job/vice-president-commercial-strategy-lyell-immunopharma-united-states-dma4kbk98ssd) — United States